Literature DB >> 11206453

Atropisomeric quinazolin-4-one derivatives are potent noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists.

W M Welch1, F E Ewing, J Huang, F S Menniti, M J Pagnozzi, K Kelly, P A Seymour, V Guanowsky, S Guhan, M R Guinn, D Critchett, J Lazzaro, A H Ganong, K M DeVries, T L Staigers, B L Chenard.   

Abstract

Piriqualone (1) was found to be an antagonist of AMPA receptors. Structure activity optimization was conducted on each of the three rings in 1 to afford a series of potent and selective antagonists. The sterically crowded environment surrounding the N-3 aryl group provided sufficient thermal stability for atropisomers to be isolated. Separation of these atropisomers resulted in the identification of (+)-38 (CP-465,022), a compound that binds to the AMPA receptor with high affinity (IC50 = 36 nM) and displays potent anticonvulsant activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11206453     DOI: 10.1016/s0960-894x(00)00622-3

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  12 in total

Review 1.  Ionotropic and metabotropic glutamate receptor structure and pharmacology.

Authors:  James N C Kew; John A Kemp
Journal:  Psychopharmacology (Berl)       Date:  2005-02-25       Impact factor: 4.530

2.  Measurement of atropisomer racemization kinetics using segmented flow technology.

Authors:  Jennifer E Davoren; Mark W Bundesmann; Qi T Yan; Elizabeth M Collantes; Scot Mente; Deane M Nason; David L Gray
Journal:  ACS Med Chem Lett       Date:  2012-03-12       Impact factor: 4.345

3.  Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists.

Authors:  Cara A Mosley; Timothy M Acker; Kasper B Hansen; Praseeda Mullasseril; Karen T Andersen; Phuong Le; Kimberly M Vellano; Hans Bräuner-Osborne; Dennis C Liotta; Stephen F Traynelis
Journal:  J Med Chem       Date:  2010-08-12       Impact factor: 7.446

4.  Styryl quinazolinones and its ethynyl derivatives induce myeloid differentiation.

Authors:  Sridhar Radhakrishnan; Riyaz Syed; Hisashi Takei; Ikei S Kobayashi; Eugene Nakamura; Farheen Sultana; Ahmed Kamal; Daniel G Tenen; Susumu S Kobayashi
Journal:  Bioorg Med Chem Lett       Date:  2019-06-20       Impact factor: 2.823

5.  Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors.

Authors:  Kasper B Hansen; Stephen F Traynelis
Journal:  J Neurosci       Date:  2011-03-09       Impact factor: 6.167

Review 6.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

Review 7.  AMPA receptors as a molecular target in epilepsy therapy.

Authors:  M A Rogawski
Journal:  Acta Neurol Scand Suppl       Date:  2013

8.  5'-Methyl-4'-oxo-7'-phenyl-3',4'-dihydro-1'H-spiro-[cyclo-hexane-1,2'-quinazoline]-8'-carbonitrile.

Authors:  Jianhong Tang; Daxin Shi; Liupan Yan; Xuan Liu; Jiarong Li
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-06-18

9.  Synthesis, Biological Evaluation and Molecular Docking Studies of 6-Aryl-2-Styrylquinazolin-4(3H)-Ones.

Authors:  Emmanuel Ndubuisi Agbo; Tshepiso Jan Makhafola; Yee Siew Choong; Malose Jack Mphahlele; Ponnadurai Ramasami
Journal:  Molecules       Date:  2015-12-25       Impact factor: 4.411

Review 10.  Positive and Negative Allosteric Modulators of N-Methyl-d-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action.

Authors:  Erica S Burnell; Mark Irvine; Guangyu Fang; Kiran Sapkota; David E Jane; Daniel T Monaghan
Journal:  J Med Chem       Date:  2018-03-05       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.